Abstract
A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Breast / drug effects
-
Clinical Trials as Topic
-
Diethylstilbestrol / administration & dosage
-
Diethylstilbestrol / pharmacology
-
Dosage Forms
-
Ergot Alkaloids / administration & dosage
-
Ergot Alkaloids / pharmacology*
-
Female
-
Follow-Up Studies
-
Humans
-
Lactation / drug effects*
-
Placebos
-
Postpartum Period*
-
Pregnancy
Substances
-
Dosage Forms
-
Ergot Alkaloids
-
Placebos
-
Diethylstilbestrol